Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use

Infectious Diseases and Therapy - United States
doi 10.1007/s40121-015-0070-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

15 Years of Transcriptomic Analysis on Endometrial Receptivity: What Have We Learnt?

Fertility Research and Practice
2019English

A Year of Guidelines: What Have We Learnt?

Australian and New Zealand Journal of Psychiatry
MedicinePsychiatryMental Health
2016English

Chinese Investments in Africa: What Have We Learnt?

Management international
2018English

What (If Anything) Have We Learned After Twenty Years?

2008English

CCR6-CCL20 Axis in IBD: What Have We Learnt in the Past 20 Years?

2018English

Cardiovascular Outcome Trials in Diabetes: What Have We Learnt?

Trends in Urology & Men's Health
2018English

Policy Learning and Social Protection: What Have We Learnt?

International Social Security Review
SociologyFinancePublic AdministrationEconomicsPolitical ScienceEconometrics
2009English

Tau Imaging in Parkinsonism - What Have We Learnt So Far?

Movement Disorders Clinical Practice
Neurology
2018English

S01.04 Lung Cancer Screening: 1999 to Date – What Have We Learnt?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy